The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Reviewing the effects of eicosapentaenoic acid on depression

    Researchers at the New York State Psychiatric Institute, in New York City, reviewed the evidence for eicosapentaenoic acid (EPA) to treat major depressive episodes.

    First, the details.

    • Data from 15 study involving 916 participants were used for the meta-analysis.

    And, the results.

    • Supplements with at least 60% EPA showed significant benefit on standardized depression scores compared to supplements with less than 60% EPA.
    • Treatment duration or age didn’t affect the results.
    • Improvement was associated with EPA doses in excess of docosahexaenoic acid (DHA), within the range of 200 to 2,200 mg/d of EPA.
    • Supplements with less than 60% EPA were ineffective.

    The bottom line?

    The authors concluded, “Supplements containing EPA at least 60% of total EPA + DHA, in a dose range of 200 to 2,200 mg/day of EPA in excess of DHA, were effective against primary depression.”

    9/28/11 22:07 JR

    Leave a Comment

    You must be logged in to post a comment.